|
|
||||||||
Eur J Cardiothorac Surg 2001;19:443-447
© 2001 Elsevier Science NL
a Department of Cardiothoracic Surgery and Department of Cardiology and Cardioanesthesiology, Ziekenhuis De Weezenlanden, Groot Wezenland 20, 8011 JW Zwolle, The Netherlands
b Academic Hospital Maastricht, Maastricht, The Netherlands
Received 12 October 2000; received in revised form 11 January 2001; accepted 13 January 2001.
Corresponding author. Tel.: +31-38-424-2866; fax: +31-38-424-3163
e-mail: hauwsie{at}worldonline.nl
| Abstract |
|---|
|
|
|---|
Key Words: Atrial fibrillation Mitral valve disease Radiofrequency
| 1. Introduction |
|---|
|
|
|---|
| 2. Materials and methods |
|---|
|
|
|---|
|
2.2. Surgical procedure
Radiofrequency energy was used to create long continuous endocardial lesions under direct vision with a hand-held cooled tip probe. The RF energy was administered using a continuous sinusoidal unmodulated waveform of 500 kHz (HAT 200S, Sulzer-Osypka GmbH, Grenzach-Wyhlen, Germany) and delivered in an unipolar mode between the 4-mm tip electrode of a specially designed probe and a 10x16-cm external backplate electrode that was underneath the back of the patient. The ablation probe had a thermistor embedded centrally in the distal part of the tip electrode for continuous monitoring of catheter tip temperature.
The ablation procedure was done in a bloodless operating field and temperature guided energy applications were performed with a preselected catheter tip temperature of 60°C. The tip was irrigated with saline at a flow rate of 4 ml/min.
The heart was exposed through a median sternotomy and suspended in a pericardial cradle. Cardiopulmonary bypass was instituted using standard aortic and bicaval cannulation and moderate hypothermia (28°C). The operative procedure was based on the maze III procedure as described by Cox et al. [9]. In our RF modification, all atrial incisions currently used in the maze III were replaced by endocardial linear ablation lines as illustrated in Fig. 1 except for the incisions to enter the left and right atrial cavity. According to the original maze III both appendages were excised as well. There was no need for additional cryosurgical applications.
|
2.3. Follow-up
Early postoperative care was similar to that for routine open-heart surgery. Cardiac rhythm was continuously monitored after surgery until stable rhythm returned. Temporary epicardial wires attached to the right ventricle as well as to the right atrium were used to pace the patient, to monitor the rhythm, or to overdrive the atrium. Postoperative atrial arrhythmias were treated with sotalol 80120 mg or amiodarone 200 mg and combined with DC cardioversion, if necessary. Patients were seen in the outpatient clinic within 4 weeks, at 3 months and at 6 months after operation, or earlier when necessary. Antiarrhythmic drugs were tapered gradually after cardiac rhythm was considered stable. Transthoracic and transesophageal Doppler echocardiography were performed at 3 and 6 months after surgery to assess atrial mechanical function. After 6 months patient status was determined by records of outpatient visits and correspondence with referring physicians.
2.4. Statistical analysis
Continuous variables were expressed as mean±standard deviation. Means were compared using Student's t-test. In the case of non-normal distribution, the nonparametric Wilcoxon test was used. A P value less than 0.05 was considered statistically significant.
| 3. Results |
|---|
|
|
|---|
|
|
3.4. Cardiac rhythm and atrial transport
At 6 months follow-up 64 survivors were free of atrial tachyarrhythmias. In these patients transthoracic or transesophageal Doppler echocardiography was performed and demonstrated right atrial contractility in 89% (57 of 64) and left atrial transport in 91% (58 of 64) of the patients.
In the most recent follow-up the number of survivors with persistent AF or atrial flutter increases to ten (15%) including two patients who underwent His bundle ablation and received a ventricular rate responsive pacemaker because of symptomatic AF. In the remaining group of patients sinus rhythm was documented in 51 (76%), a regular atrial rhythm in two (3%) and an AV sequential pacemaker was implanted in four (6%) patients. Of these patients, one patient received an AV sequential pacemaker prior to surgery in combination with His bundle ablation and another patient needed the same type of pacemaker due to sinus node dysfunction.
In the group of 57 patients who were free of AF or atrial flutter, antiarrhythmic drug therapy was maintained in 17 patients (30%). Ten patients were on sotalol 80120 mg and seven patients on amiodarone 200 mg.
| 4. Discussion |
|---|
|
|
|---|
The Cox's maze procedure [79] has apparently remained an universally applicable and potentially effective treatment to restore sinus rhythm in patients with chronic AF and concomitant structural heart disease [1921]. However, this surgical procedure involves extensive incision and suturing of the atria and in an attempt to simplify the original maze, our group [16] and others [15,17] used RF energy intraoperatively to create linear ablation lines endocardially, under direct visual guidance, to eliminate AF. The RF ablation pattern we used is based on the maze III concept [9], but most of the atrial incisions of the original maze procedure are replaced by RF lesions. As a consequence, the extra cardiac arrest time to complete the left-sided part of the maze procedure was only 1015 min.
The aim of AF surgery is restoration of sinus rhythm and reestablishment of atrial mechanical function. This was achieved in the majority of the patients in our study, which is comparable with the surgical maze III in patients with long-standing AF and structural heart disease [2024]. Cox and associates [25] demonstrated that preservation of atrial transport function was 93.6% in the right atrium and 85.1% in the left atrium after the maze III when evaluated by transthoracic Doppler echocardiography, although when additional techniques were used such as transesophageal Doppler echocardiography or magnetic resonance imaging, preservation of transport function was 98% in the right atrium and 94% in the left atrium. The high percentage of atrial contractility in this patient group in contrast to other studies [13,23,26] can be explained by the use of transesophageal Doppler echocardiography to assess atrial transport function while others have relied on transthoracic Doppler echocardiography as a means to show atrial contractility. Furthermore, we have observed immediate recovery of left atrial function in the majority of patients undergoing intraoperative RF ablation for chronic AF, using transesophageal Doppler echocardiography in the operating theatre [27].
Finally, radiofrequency ablation applied at limited epicardial and or endocardial sites in patients with AF during MV surgery showed promising results [15,28], but in contrast to our patient population, these studies also included patients with paroxysmal AF and AF duration less than 1 year and, according to recent studies [1,18] these patients have a higher likelihood to remain in sinus rhythm after surgery.
| Footnotes |
|---|
| Appendix A. Conference discussion |
|---|
|
|
|---|
In addition, how many patients were maintained on anti-arrhythmic medication postoperatively?
Dr Sie: Let's start with the second question. We have to look at the number of patients that are still on anti-arrhythmic medication. Our primary goal was to restore sinus rhythm and to restore atrial contractility, and all the secondary effects and secondary goals we didn't look at it yet, but we still have to do that.
An answer to the first question regarding the transmurality of the lesion is that during the procedure we are trying to give as much energy as possible to make a transmural lesion but without disrupting the tissue. So whenever I feel insecure whether the lesion will be transmural or not, e.g. because of the thickness of the tissue in a certain area, I will go back to that particular area and repeat the ablation. During the procedure I am actually dragging the probe along the wall of the atrium endocardially, and whenever it starts to pop up, I will stop the procedure at that specific site and then move on.
Dr S. Benussi (Milan, Italy): My perplexity is actually the opposite to that of my colleague. Aren't you concerned by using the drag technique, without any temperature control system, to go too deep, and to damage or to disrupt in any way the underlying structures, such as the esophagus or the circumflex artery?
Another question that can be interesting is, how can you obtain such very good results on atrial transport function recovery by reproducing exactly the same lesion set that is performed in the Maze procedure with incisions? What is the difference and what do you think is the rationale for that?
And one last question is about your atrial flutter. About a 15% occurrence of atrial flutter with this kind of procedure is actually quite strange, because you are supposed to have cut through the isthmus. So which kind of flutter is that? Is that conventional right atrial flutter?
Dr Sie: We try to prevent this post-maze flutter by ablation of the isthmus. We performed some postoperative studies with the CARTO system and found that there still was a gap along the tricuspid annulus in some of our patients. So currently we are somewhat more aggressively ablating at this particular annular site. What was the second question you asked?
Dr Benussi: The concerns about the excessive transmurality.
Dr Sie: The difference with the Cox-maze is that in the Cox-maze both pulmonary veins are totally encircled and isolated. We know that especially in enlarged atria, the enlargement will grossly take place between the left and the right pulmonary veins. By isolating this particular part you will exclude a considerable amount of tissue. In our RF modification we try to preserve as much tissue as possible by isolating left and right pulmonary veins separately.
Regarding the concern about damaging the surrounding tissue, as you have seen on the histological slide, one of the limitations of the RF technique is the depth of the lesion. So we are more concerned about transmurality. We did not experience any damage of the surrounding tissue whatsoever.
Dr J. Melo (Carnaxide, Portugal): In your accepted abstract you have reported 122 patients. You have shown us 72 patients only. So your success rate in the other 50 was the same?
Dr Sie: At our latest update of June 2000 a total of 158 patients were enrolled in our study and followed up for at least 3 months. The series I just presented was confined to a subgroup of 72 patients undergoing the RF-maze procedure concomitant with solely mitral valve surgery. The mortality rate was lower in the subgroup with 2.4% instead of 4.2% for the total group. The success rate in the subgroup was comparable with the total group.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Melo, T. Santiago, C. Aguiar, E. Berglin, M. Knaut, O. Alfieri, S. Benussi, H. Sie, M. Williams, F. Hornero, et al. Surgery for atrial fibrillation in patients with mitral valve disease: Results at five years from the International Registry of Atrial Fibrillation Surgery. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 863 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wisser, G. Seebacher, T. Fleck, C. Aigner, C. Khazen, G. Stix, D. Hutschala, and E. Wolner Permanent Chronic Atrial Fibrillation: Is Pulmonary Vein Isolation Alone Enough? Ann. Thorac. Surg., October 1, 2007; 84(4): 1151 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stulak, J. A. Dearani, T. M. Sundt III, R. C. Daly, C. G.A. McGregor, K. J. Zehr, and H. V. Schaff Superiority of cut-and-sew technique for the Cox maze procedure: Comparison with radiofrequency ablation J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1022 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Martin-Suarez, B. Claysset, L. Botta, M. Ferlito, D. Pacini, C. Savini, G. Marinelli, and R. DiBartolomeo Surgery for atrial fibrillation with radiofrequency ablation: four years experience Interactive CardioVascular and Thoracic Surgery, February 1, 2007; 6(1): 71 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillinov Advances in Surgical Treatment of Atrial Fibrillation Stroke, February 1, 2007; 38(2): 618 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jahangiri, G. Weir, K. Mandal, I. Savelieva, and J. Camm Current strategies in the management of atrial fibrillation. Ann. Thorac. Surg., July 1, 2006; 82(1): 357 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Melo Surgery for atrial fibrillation: Are we heading in the right direction? J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 949 - 951. [Full Text] [PDF] |
||||
![]() |
S. S Kabbani, G. Murad, H. Jamil, A. Sabbagh, and K. Hamzeh Ablation of Atrial Fibrillation Using Microwave Energy - Early Experience Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 247 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A.C. Abreu Filho, L. A.F. Lisboa, L. A.O. Dallan, G. S. Spina, M. Grinberg, M. Scanavacca, E. A. Sosa, J. A. F. Ramires, and S. A. Oliveira Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease Circulation, August 30, 2005; 112(9_suppl): I-20 - I-25. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Khargi, B. Lemke, and T. Deneke Concomitant anti-arrhythmic procedures to treat permanent atrial fibrillation in CABG and AVR patients are as effective as in mitral valve patients Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 841 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fayad, T. Le Tourneau, T. Modine, R. Azzaoui, P.-V. Ennezat, C. Decoene, G. Deklunder, and H. Warembourg Endocardial Radiofrequency Ablation During Mitral Valve Surgery: Effect on Cardiac Rhythm, Atrial Size, and Function Ann. Thorac. Surg., May 1, 2005; 79(5): 1505 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fasol, J. Meinhart, and T. Binder A modified and simplified radiofrequency ablation in patients with mitral valve disease J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 215 - 217. [Full Text] [PDF] |
||||
![]() |
J P Bourke, A Dunuwille, D O'Donnell, S Jamieson, and S S Furniss Pulmonary vein ablation for idiopathic atrial fibrillation: six month outcome of first procedure in 100 consecutive patients Heart, January 1, 2005; 91(1): 51 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. A. Szalay, A. Civelek, T. Dill, W. P. Klovekorn, I. Kilb, and E. P. Bauer Long-term follow-up after the mini-maze procedure Ann. Thorac. Surg., April 1, 2004; 77(4): 1277 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Santiago, J. Melo, R. H. Gouveia, J. Neves, M. Abecasis, P. Adragao, and A. P. Martins Epicardial radiofrequency applications: in vitro and in vivo studies on human atrial myocardium Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 481 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Akpinar, M. Guden, E. Sagbas, I. Sanisoglu, U. Ozbek, B. Caynak, and O. Bayindir Combined radiofrequency modified maze and mitral valve procedure through a port access approach: early and mid-term results Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 223 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T Sie, W. P Beukema, A. Elvan, and A. R Ramdat Misier New strategies in the surgical treatment of atrial fibrillation Cardiovasc Res, June 1, 2003; 58(3): 501 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Santiago, J. Q. Melo, R. H. Gouveia, and A. P. Martins Intra-atrial temperatures in radiofrequency endocardial ablation: histologic evaluation of lesions Ann. Thorac. Surg., May 1, 2003; 75(5): 1495 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Demaria, P. Page, T. K. Leung, M. Dubuc, O. Malo, M. Carrier, and L. P. Perrault Surgical radiofrequency ablation induces coronary endothelial dysfunction in porcine coronary arteries Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 277 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillinov, E. H. Blackstone, and P. M. McCarthy Atrial fibrillation: current surgical options and their assessment Ann. Thorac. Surg., December 1, 2002; 74(6): 2210 - 2217. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guden, B. Akpinar, I. Sanisoglu, E. Sagbas, and O. Bayindir Intraoperative saline-irrigated radiofrequency modified Maze procedure for atrial fibrillation Ann. Thorac. Surg., October 1, 2002; 74(4): S1301 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakajima, J. Kobayashi, K. Bando, K. Niwaya, O. Tagusari, Y. Sasako, T. Nakatani, and S. Kitamura The Effect of Cryo-Maze Procedure on Early and Intermediate Term Outcome in Mitral Valve Disease: Case Matched Study Circulation, September 24, 2002; 106(12_suppl_1): I-46 - I-50. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jais, R. Weerasooriya, D. C. Shah, M. Hocini, L. Macle, K.-J. Choi, C. Scavee, M. Haissaguerre, and J. Clementy Ablation therapy for atrial fibrillation (AF): Past, present and future Cardiovasc Res, May 1, 2002; 54(2): 337 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pasic, P. Bergs, P. Muller, M. Hofmann, O. Grauhan, H. Kuppe, and R. Hetzer Intraoperative radiofrequency maze ablation for atrial fibrillation: the Berlin modification Ann. Thorac. Surg., November 1, 2001; 72(5): 1484 - 1491. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |